In breast cancer, mucin 1-C binds to the CD44 variant to stabilize the SLC7A11 molecule, while H3K9me2/3 on the Mucin 1-C promoter suppresses its transcription, thereby affecting GPX4’s capacity to induce ferroptosis [92]. Here, GPX4 is linked to breast cancer.